Abstract:Background and Hypothesis
The acquired von Willebrand syndrome (AvWS), which predisposes to bleeding events, is often related to valvular heart diseases. We investigated possible implications of AvWS and factor VIII levels in patients with moderate to severe mitral regurgitation (MR) undergoing transcatheter mitral valve repair (TMVR).
Methods and Results
123 patients with moderate to severe MR were prospectively enrolled. Complete measurements of von Willebrand Factor activity (vWFAct), von Willebrand Factor … Show more
“…There are reports of moderate or severe native mitral regurgitation to be associated with abnormal VWF multimers and clinically significant GI bleeding, which reversed after mitral valve surgery [ 15 ]. In 123 patients with moderate or severe native mitral regurgitation undergoing transcatheter mitral valve repair, Meindl et al reported that an elevated mean mitral valve gradient following transcatheter mitral valve repair was associated with a low post-procedure VWF activity [ 16 ]. However, this alteration did not translate into a higher incidence of bleeding events.…”
IntroductionWe sought to investigate the association between left-sided prosthetic valve dysfunction and gastrointestinal (GI) bleeding.
MethodsIn a retrospective cohort of patients with left-sided prostheses, we identified those who experienced one or more GI bleeds. The latest or chronologically closest echocardiogram to the GI bleed was analyzed by a blinded investigator for prosthetic valve dysfunction.
ResultsAmong 334 unique patients, 166 had aortic prostheses, 127 had mitral prostheses, and 41 had both. A total of 58 (17.4%) subjects had GI bleeding events. Patients in the "GI Bleed" group had higher mean ejection fraction (56±14% vs. 49±15%; P = 0.003) and higher prevalence of hypertension, end-stage renal disease, and liver cirrhosis compared to the "No GI Bleed" group. There was a higher prevalence of moderate or severe prosthetic valve regurgitation in the GI Bleed vs. No GI Bleed group (8.6% vs. 2.2%; P = 0.027). Moderate or severe prosthetic valve regurgitation was independently associated with GI bleeding (odds ratio, 6.18; 95% confidence interval, 1.27-30.05; P = 0.024), after adjusting for ejection fraction, hypertension, end-stage renal disease and liver cirrhosis. Paravalvular regurgitation was associated with a higher incidence of GI bleeding compared to transvalvular regurgitation (35.7% vs. 11.9%; P = 0.044). The prevalence of prosthetic valve stenosis was similar between the GI Bleed and No GI Bleed groups (6.9% vs. 5.8%; P = 0.761).
ConclusionIn a cohort of patients with predominantly surgically placed prosthetic valves, moderate to severe left-sided prosthetic valve regurgitation was independently associated with GI bleeding.
“…There are reports of moderate or severe native mitral regurgitation to be associated with abnormal VWF multimers and clinically significant GI bleeding, which reversed after mitral valve surgery [ 15 ]. In 123 patients with moderate or severe native mitral regurgitation undergoing transcatheter mitral valve repair, Meindl et al reported that an elevated mean mitral valve gradient following transcatheter mitral valve repair was associated with a low post-procedure VWF activity [ 16 ]. However, this alteration did not translate into a higher incidence of bleeding events.…”
IntroductionWe sought to investigate the association between left-sided prosthetic valve dysfunction and gastrointestinal (GI) bleeding.
MethodsIn a retrospective cohort of patients with left-sided prostheses, we identified those who experienced one or more GI bleeds. The latest or chronologically closest echocardiogram to the GI bleed was analyzed by a blinded investigator for prosthetic valve dysfunction.
ResultsAmong 334 unique patients, 166 had aortic prostheses, 127 had mitral prostheses, and 41 had both. A total of 58 (17.4%) subjects had GI bleeding events. Patients in the "GI Bleed" group had higher mean ejection fraction (56±14% vs. 49±15%; P = 0.003) and higher prevalence of hypertension, end-stage renal disease, and liver cirrhosis compared to the "No GI Bleed" group. There was a higher prevalence of moderate or severe prosthetic valve regurgitation in the GI Bleed vs. No GI Bleed group (8.6% vs. 2.2%; P = 0.027). Moderate or severe prosthetic valve regurgitation was independently associated with GI bleeding (odds ratio, 6.18; 95% confidence interval, 1.27-30.05; P = 0.024), after adjusting for ejection fraction, hypertension, end-stage renal disease and liver cirrhosis. Paravalvular regurgitation was associated with a higher incidence of GI bleeding compared to transvalvular regurgitation (35.7% vs. 11.9%; P = 0.044). The prevalence of prosthetic valve stenosis was similar between the GI Bleed and No GI Bleed groups (6.9% vs. 5.8%; P = 0.761).
ConclusionIn a cohort of patients with predominantly surgically placed prosthetic valves, moderate to severe left-sided prosthetic valve regurgitation was independently associated with GI bleeding.
“…There are reports of moderate or severe native mitral regurgitation to be associated with abnormal VWF multimers and clinically signi cant GI bleeding, which reversed after mitral valve surgery (12). In 123 patients with moderate or severe native mitral regurgitation undergoing transcatheter mitral valve repair, Meindl et al reported that an elevated mean mitral valve gradient following transcatheter mitral valve repair was associated with a low post-procedure VWF activity (13). However, this alteration did not translate into a higher incidence of bleeding events.…”
The association between left-sided prosthetic valve (PV) dysfunction and gastrointestinal (GI) bleeding is not well established. In a retrospective cohort of patients with left-sided prostheses, we identified those who experienced one or more GI bleeds. The latest or chronologically closest echocardiogram to the GI bleed was analyzed by a blinded investigator for PV dysfunction. Among 334 unique patients, 166 had aortic prostheses, 127 had mitral prostheses, and 41 had both. A total of 58 (17.4%) subjects had GI bleeding events. Patients in the “GI Bleed” group had higher mean ejection fraction (56 ± 14% vs. 49 ± 15%; P = 0.003) and higher prevalence of hypertension, end-stage renal disease, and liver cirrhosis compared to the “No GI Bleed” group. There was a higher prevalence of moderate or severe PV regurgitation in the GI Bleed vs. No GI Bleed group (8.6% vs. 2.2%; P = 0.027). Moderate or severe prosthetic valve regurgitation was independently associated with GI bleeding (odds ratio, 6.18; 95% confidence interval, 1.27–30.05; P = 0.024), after adjusting for ejection fraction, hypertension, end-stage renal disease and liver cirrhosis. Paravalvular regurgitation was associated with a higher incidence of GI bleeding compared to transvalvular regurgitation (35.7% vs. 11.9%; P = 0.044). The prevalence of PV stenosis was similar between the GI Bleed and No GI Bleed groups (6.9% vs. 5.8%; P = 0.761). In conclusion, among patients with predominantly surgically placed PV, moderate to severe left-sided PV regurgitation was independently associated with GI bleeding. PV stenosis was not associated with GI bleeding.
“…The bleeding is typically attributed to gastrointestinal angiodysplasia, fragile and abnormal vessels immediately beneath the mucosa [ 8 ]. In addition to , hypertrophic obstructive cardiomyopathy [ 9 ], pulmonary hypertension [ 10 ], congenital structural heart diseases [ 11 ], mitral regurgitation (MR) [ [12] , [13] , [14] , [15] , [16] ], and mechanical circulatory support [ 17 , 18 ] have also been previously reported to cause AVWS.…”
Section: Introductionmentioning
confidence: 99%
“…MR has been reported as a cause of AVWS in several studies [ [12] , [13] , [14] , [15] , [16] ]. Blackshear et al.…”
Section: Introductionmentioning
confidence: 99%
“…[ 12 ] also reported that VWF function improved significantly in all patients after open-heart surgery with mitral valve plasty or mitral valve replacement, while Meindl et al. [ 13 ] showed that VWF activity/antigen ratios in patients who underwent transcatheter mitral valve repair did not improve 4 weeks after the procedure.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.